Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A-kinase anchoring protein 1 (AKAP1) is a mitochondrial scaffold protein that anchors protein kinase A (PKA) and other signaling proteins to the outer mitochondrial membrane, orchestrating localized signal transduction events[2][4]. It plays a critical role in regulating mitochondrial dynamics by inhibiting fission and promoting fusion, thereby maintaining mitochondrial integrity and function[1][4]. AKAP1 modulates oxidative phosphorylation and ATP production, buffers mitochondrial calcium, reduces reactive oxygen species (ROS), and prevents apoptosis in stressed cells, conferring cardioprotective and neuroprotective effects[1][2][4]. AKAP1 is implicated in the regulation of pathological cardiac hypertrophy, heart failure, neurodegenerative diseases, and cancer, acting largely by controlling mitochondrial homeostasis and cell survival signaling. Loss or downregulation of AKAP1 leads to enhanced mitochondrial fragmentation, oxidative stress, and cell death, particularly in cardiomyocytes and neurons[1][2][4]. There are currently no approved drugs specifically targeting AKAP1, but its central role in disease pathways makes it a potential therapeutic target[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on A-kinase anchoring protein 1 (AKAP1).